Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients.
作者信息
Hengeveld Paul J, Schilperoord-Vermeulen Joyce, Kolijn P Martijn, Dubois Julie M N, Westerweel Peter E, Kersting Sabina, Kater Arnon P, Levin Mark-David, Langerak Anton W
机构信息
Department of Immunology, Laboratory of Medical Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
出版信息
Blood Cancer J. 2025 Jan 7;15(1):2. doi: 10.1038/s41408-025-01209-9.
Abstract
摘要
Zotero 插件